English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

94 hrombocytopenia is the most common hematological complication following anemia during pregnancy, and is observed in 6-10% of all pregnancies.1,2 It is categorized into mild, moderate, and severe thrombocytopenia, based on thrombocyte counts between 100,000150,000/mm3, 50,000-100,000/mm3, and <50,000/mm3, respectively.3 Gestational thrombocytopenia (GT) is the most common cause and is observed in approximately 75% of the cases. Preeclampsia, eclampsia, and HELLP cases are among the other pregnancy-specific etiologic factors. The causes of thrombocytopenia that are not specific to pregnancy include primary immune thrombocytopenia; viral infections such as hepatitis B virus (HBV), cytomegalovirus (CMV), Epstein-Barr virus (EBV); secondary immune thrombocytopenia related to autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid antibodies; thrombotic micro-angiopathies such as thrombotic thrombocytopenic purpura and hemolytic ureMaternal-Fetal Outcomes of Pregnancies with Thrombocytopenia-One Center Experience